These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 16554372)
1. Comparison of drug efflux transport kinetics in various blood-brain barrier models. Bachmeier CJ; Trickler WJ; Miller DW Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372 [TBL] [Abstract][Full Text] [Related]
2. Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF. Bachmeier CJ; Trickler WJ; Miller DW J Pharm Sci; 2004 Apr; 93(4):932-42. PubMed ID: 14999730 [TBL] [Abstract][Full Text] [Related]
3. Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport. Gibbs JP; Adeyeye MC; Yang Z; Shen DD Epilepsy Res; 2004 Jan; 58(1):53-66. PubMed ID: 15066675 [TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro evidence for nonrestricted transport of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier. Hirohashi T; Terasaki T; Shigetoshi M; Sugiyama Y J Pharmacol Exp Ther; 1997 Feb; 280(2):813-9. PubMed ID: 9023295 [TBL] [Abstract][Full Text] [Related]
5. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564 [TBL] [Abstract][Full Text] [Related]
6. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082 [TBL] [Abstract][Full Text] [Related]
7. Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells. Acharya P; O'Connor MP; Polli JW; Ayrton A; Ellens H; Bentz J Drug Metab Dispos; 2008 Feb; 36(2):452-60. PubMed ID: 17967933 [TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein. Woodahl EL; Yang Z; Bui T; Shen DD; Ho RJ J Pharmacol Exp Ther; 2004 Sep; 310(3):1199-207. PubMed ID: 15100388 [TBL] [Abstract][Full Text] [Related]
9. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869 [TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein. Neuhaus W; Stessl M; Strizsik E; Bennani-Baiti B; Wirth M; Toegel S; Modha M; Winkler J; Gabor F; Viernstein H; Noe CR Neurosci Lett; 2010 Jan; 469(2):224-8. PubMed ID: 19963040 [TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier. Bachmeier CJ; Spitzenberger TJ; Elmquist WF; Miller DW Pharm Res; 2005 Aug; 22(8):1259-68. PubMed ID: 16078135 [TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice. Park S; Sinko PJ J Pharmacol Exp Ther; 2005 Mar; 312(3):1249-56. PubMed ID: 15528451 [TBL] [Abstract][Full Text] [Related]
14. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats. Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062 [TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists. Smith BJ; Doran AC; McLean S; Tingley FD; O'Neill BT; Kajiji SM J Pharmacol Exp Ther; 2001 Sep; 298(3):1252-9. PubMed ID: 11504828 [TBL] [Abstract][Full Text] [Related]
16. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier. Hsiao P; Bui T; Ho RJ; Unadkat JD Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117 [TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir. Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Hyafil F; Vergely C; Du Vignaud P; Grand-Perret T Cancer Res; 1993 Oct; 53(19):4595-602. PubMed ID: 8402633 [TBL] [Abstract][Full Text] [Related]
19. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Taub ME; Podila L; Ely D; Almeida I Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers. Miller DW; Hinton M; Chen F Neurourol Urodyn; 2011 Nov; 30(8):1633-8. PubMed ID: 21826715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]